Complex genetics of drug resistance in Mycobacterium tuberculosis
- 26 September 2013
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 45 (10) , 1107-1108
Abstract
Three new studies have used whole-genome sequencing of M. tuberculosis to demonstrate unexpected complexity in the modern evolution of drug-resistant tuberculosis, and a fourth study suggests a close evolutionary relationship between the pathogen and its human host over a period of 70,000 years. Collectively, the observations in these studies suggest that future strategies to tackle drug-resistant tuberculosis must integrate host genetics with detailed strain epidemiology.Keywords
This publication has 16 references indexed in Scilit:
- The Role of Selection in Shaping Diversity of Natural M. tuberculosis PopulationsPLOS Pathogens, 2013
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomasNature Genetics, 2013
- In Vitro Combination Studies of Benzothiazinone Lead Compound BTZ043 against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2012
- Global Assessment of Genomic Regions Required for Growth in Mycobacterium tuberculosisPLOS Pathogens, 2012
- Dynamic Population Changes in Mycobacterium tuberculosis During Acquisition and Fixation of Drug Resistance in PatientsThe Journal of Infectious Diseases, 2012
- Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosisScience, 2011
- Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 BindingScience, 2011
- The ins and outs of Mycobacterium tuberculosis drug susceptibility testingClinical Microbiology and Infection, 2011
- Mycobacterial PE/PPE Proteins at the Host-Pathogen InterfaceJournal of Immunology Research, 2011
- Mutations in Extensively Drug‐ResistantMycobacterium tuberculosisThat Do Not Code for Known Drug‐Resistance MechanismsThe Journal of Infectious Diseases, 2010